Lori Braender is chair of the Life Sciences practice group, and has experience in representing pharmaceutical, biotechnology, and medical device companies, hospitals, and other healthcare institutions, physicians, and medical group practices in a variety of matters. She has served as lead counsel in a number of these matters, including structuring and negotiating acquisitions, joint ventures, affiliation and collaboration agreements, cross-border licensing and managed-care arrangements. Lori specializes in advising clients on business considerations and regulatory requirements in life science and healthcare transactions and contractual arrangements, including on, fraud and abuse issues, licensing, and credentialing and approval matters. She acts in the capacity of general counsel for several clients advising them on day-to-day business operations and long-term strategy.
Lori's corporate practice involves general commercial law, including stock and asset acquisitions, mergers, corporate reorganizations, general and limited partnership matters, limited liability company matters, equipment leasing, product manufacturing and distribution agreements, and employment and consulting agreements. She also counsels clients with regard to private placements and tax-exempt, asset-based and unsecured financings.
Lori has experience in intellectual property law, including trademark and copyright matters, computer software and patent licensing, distribution agreements, and technology development agreements. She also advises clients with regard to construction law, including architects and contractors agreements, design/build agreements, and turnkey projects.